Comparison of Cisplatin with Lipoplatin in Terms of Ototoxicity

Abstract

OBJECTIVE: Cisplatin (CDDP) is an anti-neoplastic agent that has been used in treatments of both pediatric and adult cancers. It has many side effects, such as ototoxicity, nephrotoxicity, and neurotoxicity. Lipoplatin (LIPO) is a nanomolecule with 110 nm diameter and composed of lipids and CDDP. In this study, we aimed to compare the toxic effects of LIPO with CDDP in the cochlear cells with anti-tumoral doses determined in neuroblastoma cells. MATERIALS and METHODS:House Ear Institute Organ Corti 1 (HEI-OC1), MYC-N amplified KELLY, and MYC-N non-amplified SH-SY5Y human neuroblastoma cells were used in this study. Firstly, anti-tumoral lethal dose 50 (LD50) of LIPO and CDDP were determined using the WST-1 assay in both neuroblastoma cells. Then anti-tumoral doses of CDDP and LIPO were applied on HEI-OC1 cells for evaluating the toxic effects. The apoptotic cell death was measured using flow cytometric analysis of annexin-V/7-amino-actinomycin (7-AAD) and cell cycle tests. RESULTS:LIPO or CDDP inhibited cell viability in a dose-and time-dependent manner in both neuroblastoma and HEI-OC1 cells. LD50 values were selected as 20 mM for CDDP and 750 mM for LIPO in neuroblastoma cells. After the 48-hour incubation, KELLY cells treated with 20 mM CDDP and 750 mM LIPO had a 53% viability; SH-SY5Y cells treated 20 mM CDDP and 750 mM LIPO had a 45% and 58% viability, respectively; and HEI-OC1 cells treated with 20 mM CDDP and 750 mM LIPO had a 65% and 82% viability, respectively. CONCLUSION: LIPO showed less toxic effects in the HEI-OC1 cells compared to CDDP at anti-tumoral doses.

Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy

“…Since a large percent of cisplatin in the cell is inactivated by GSH into GS-Pt, Ishikawa surprisingly found that GS-Pt can also inactivate TrxR. 58 In the presence of cisplatin, cells also produce increased level of stress response and DNA-binding proteins.…”

Long Noncoding RNA PRNCR1 Reduces Renal Epithelial Cell Apoptosis in Cisplatin-Induced AKI by Regulating miR-182-5p/EZH1

“…It is well known that cisplatin is one of the classic broad-spectrum chemotherapy drugs used to treat tumors but can cause severe nephrotoxicity during treatment [33]. The pathological process of renal damage caused by cisplatin mainly includes inflammation of renal tubular epithelial cells, apoptosis, and even necrosis.…”

The Impact of Oleuropein on Cisplatin-Induced Toxicity in Cochlear Cells in Relation to the Expression of Deoxyribonucleic Acid Damage-Associated Genes

“…Cells were grown with 1% L-glutamine and 10% fetal bovine serum added to high-glucose DMEM (Gibco) at 33˚C incubator conditions. 13 The cells were grown in different quantities depending on the type of analysis. Oleuropein and CDDP were purchased from Sigma-Aldrich.…”